A pharmacokinetic study was conducted to compare intraindividual systemic exposures after dermal application of BT gel ( 007 % , 018 % and 05 % ) under maximal use conditions in patients with moderate-to-severe facial erythema associated with rosacea , and administration of BT ophthalmic solution 02 % .